Frontage Labs purchases early-phase clinical trial business in US
The acquisition allows future investment and improves Frontage’s existing capabilities and service offerings.

The acquisition allows future investment and improves Frontage’s existing capabilities and service offerings.
The spin-off will result in a contract research organization that will manage Phase I-IV clinical trials.
IRT systems can make or break a clinical trial. Experts have some advice for finding the right provider.
ByWhile many CROs and sponsors already use eTMF, there are still ways to make the most of the technology.
ByThrough the merger with Aventiv, Centricity now provides CROs and sponsors access to 45 clinical trial sites.
Labcorp can utilise the HealthVerity IPGE platform to align de-identified patient data with greater accuracy.
Early phase cancer drug trials need specialised sites and staff, especially since these studies target specific patients.
ByDCT Adoption Tracker: Clear regulatory guidance, existing healthcare infrastructure, and local culture are key influencers for swift decentralisation uptake.
ByThank you for subscribing to Clinical Trials Arena